Literature DB >> 30848473

Citrullinemia Type 1: Behavioral Improvement with Late Liver Transplantation.

Aashika Janwadkar1, Nikhil Shirole1, Aabha Nagral2, Rochana Bakshi3, Suresh Vasanth3, Abhijit Bagde4, Vijay Yewale5, Darius Mirza6.   

Abstract

Citrullinemia Type 1 (also known as classic citrullinemia) is a rare autosomal recessive urea cycle disorder due to reduced activity of argininosuccinate synthetase 1; characterized by hyperammonemia leading to neurological damage. The authors report a case of an 8-y boy who was diagnosed with Citrullinemia Type 1 at birth which was anticipated prenatally due to family history. His diagnosis was confirmed as a homozygous mutation (Exon 15: c.1168G > A (p.G390R)) of ASS gene. Inspite of being on a protein-free diet and ammonia scavenging treatment; the patient developed recurrent episodes of encephalopathy and seizures; complicated with behavioral issues. The patient underwent living related liver-transplantation from his mother (heterozygous carrier of the same mutation). Peri-transplant management of ammonia and plasma amino acid levels is challenging and has been highlighted. It is important to consider liver transplantation as it corrects the genetic deficiency of ASS resulting in the reversal of neuro-behavioral changes, as was seen in index patient.

Entities:  

Keywords:  Arginosuccinate synthetase; Hyperammonemia; Living donor liver transplantation; Metabolic liver disease; Urea cycle defect

Mesh:

Substances:

Year:  2019        PMID: 30848473     DOI: 10.1007/s12098-019-02905-8

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  6 in total

1.  Citrullinemia type 1: genetic diagnosis and prenatal diagnosis in subsequent pregnancy.

Authors:  G Karthikeyan; Sujatha Jagadeesh; Suresh Seshadri; J Häberle
Journal:  Indian Pediatr       Date:  2013-10       Impact factor: 1.411

2.  A pediatric patient with classical citrullinemia who underwent living-related partial liver transplantation.

Authors:  K Ban; N Sugiyama; K Sugiyama; Y Wada; T Suzuki; T Hashimoto; K Kobayashi
Journal:  Transplantation       Date:  2001-05-27       Impact factor: 4.939

3.  Early orthotopic liver transplantation in urea cycle defects: follow up of a developmental outcome study.

Authors:  Philippe M Campeau; Penelope J Pivalizza; Geoffrey Miller; Kim McBride; Saul Karpen; John Goss; Brendan H Lee
Journal:  Mol Genet Metab       Date:  2010-02-19       Impact factor: 4.797

4.  Long-term survival after liver transplantation in children with metabolic disorders.

Authors:  Liise K Kayler; Robert M Merion; Samuel Lee; Randall S Sung; Jeffrey D Punch; Steven M Rudich; Jeremiah G Turcotte; Darrell A Campbell; Ronald Holmes; John C Magee
Journal:  Pediatr Transplant       Date:  2002-08

5.  Liver transplantation for neonatal-onset citrullinemia.

Authors:  Roshni Vara; Anil Dhawan; Maesha Deheragoda; Stephanie Grünewald; Germaine Pierre; Nigel D Heaton; Hector Vilca-Melendez; Nedim Hadžić
Journal:  Pediatr Transplant       Date:  2018-05-03

Review 6.  Suggested guidelines for the diagnosis and management of urea cycle disorders.

Authors:  Johannes Häberle; Nathalie Boddaert; Alberto Burlina; Anupam Chakrapani; Marjorie Dixon; Martina Huemer; Daniela Karall; Diego Martinelli; Pablo Sanjurjo Crespo; René Santer; Aude Servais; Vassili Valayannopoulos; Martin Lindner; Vicente Rubio; Carlo Dionisi-Vici
Journal:  Orphanet J Rare Dis       Date:  2012-05-29       Impact factor: 4.123

  6 in total
  1 in total

Review 1.  Novel Gene-Correction-Based Therapeutic Modalities for Monogenic Liver Disorders.

Authors:  Mahsa Ghasemzad; Mahdieh Hashemi; Zohre Miri Lavasani; Nikoo Hossein-Khannazer; Haleh Bakhshandeh; Roberto Gramignoli; Hani Keshavarz Alikhani; Mustapha Najimi; Saman Nikeghbalian; Massoud Vosough
Journal:  Bioengineering (Basel)       Date:  2022-08-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.